tiprankstipranks

Insider Profile

Followed by 4 followers
.
Douglas Swirsky

Douglas Swirsky

GenVec Inc (GNVC)
President & CEO, Director
Ranked #86,374 out of 95,597 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-36.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$192K
51.11%
48.89%
0.00%
A breakdown of Douglas Swirsky's holdings

Insider Roles

Ocuphire Pharma
(OCUP)
President & CEO, Director
Cellectar Biosciences
(CLRB)
Director
NeuroBo Pharmaceuticals
(NRBO)
Director
Roles that Douglas Swirsky holds in companies

Most Profitable Insider Trade

Stock:
GenVec Inc
(GNVC)
Rating:Informative Buy
Date:Sep 16, 2016 - Sep 16, 2017
Return:+52.30%
The most profitable trade made by Douglas Swirsky

Douglas Swirsky's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GNVC
GenVec Inc
Jun 20, 2017
Uninformative Sell
$1.74M
Cellectar Biosciences
Sep 14, 2021
Director
Informative Buy
$26.00K
$93.75K
PTXTQ
Pernix Therapeutics
Ocuphire Pharma
Jan 30, 2019
President & CEO, Director
Informative Buy
$31.50K
$98.00K
NeuroBo Pharmaceuticals
Director
FCSC
Fibrocell Science
$0.00
List of latest transactions for each holding click on a transaction to see Douglas Swirsky's performance on stock